Journey Medical (DERM) Intangibles (2020 - 2026)

Journey Medical's Intangibles history runs 7 years deep, the most recent figure standing at $26.5 million for Q1 2026.

• Quarterly Intangibles fell 14.02% year-over-year to $26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (down 14.02% YoY) and the FY2025 annual result came in at $27.6 million, down 13.36% from the prior year.
• Intangibles was $26.5 million for Q1 2026 at Journey Medical, down from $27.6 million in the prior quarter.
• Across five years, Intangibles topped out at $31.9 million in Q4 2024 and bottomed at $17.8 million in Q3 2024.
• A 5-year average of $25.7 million and a median of $27.2 million in 2022 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles surged 117.93% — and 2023, when it decreased 25.76%.
• Journey Medical's Intangibles stood at $27.2 million in 2022, then dropped by 25.41% to $20.3 million in 2023, then soared by 57.06% to $31.9 million in 2024, then decreased by 13.36% to $27.6 million in 2025, then fell by 4.08% to $26.5 million in 2026.
• Business Quant data shows DERM's Intangibles at $26.5 million in Q1 2026, $27.6 million in Q4 2025, and $28.7 million in Q3 2025.